DB
TAK icon

Dmitry Balyasny’s Takeda Pharmaceutical TAK Stock Holding History

Dmitry Balyasny’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.2M Buy
511,336
+370,758
+264% +$6.14M 0.01% 1142
2026
Q1 		$2.6M Sell
140,578
-446
-0.3% -$7.83K ﹤0.01% 1672
2025
Q4 		$2.2M Buy
+141,024
New +$2.02M ﹤0.01% 1804
2025
Q3 		– Sell
-12,217
Closed -$189K – 3456
2025
Q2 		$189K Buy
12,217
+444
+4% +$6.56K ﹤0.01% 2611
2025
Q1 		$175K Sell
11,773
-181,430
-94% -$2.54M ﹤0.01% 2612
2024
Q4 		$2.56M Buy
+193,203
New +$2.65M ﹤0.01% 1582
2024
Q2 		– Sell
-15,354
Closed -$213K – 3099
2024
Q1 		$213K Buy
+15,354
New +$223K ﹤0.01% 2377
2023
Q4 		– Sell
-21,007
Closed -$325K – 2892
2023
Q3 		$325K Sell
21,007
-12,338
-37% -$191K ﹤0.01% 1881
2023
Q2 		$524K Buy
+33,345
New +$546K ﹤0.01% 1844
2022
Q4 		– Sell
-56,522
Closed -$733K – 3224
2022
Q3 		$733K Buy
56,522
+41,686
+281% +$580K ﹤0.01% 1924
2022
Q2 		$208K Buy
+14,836
New +$212K ﹤0.01% 2195
2021
Q3 		– Sell
-58,677
Closed -$988K – 2409
2021
Q2 		$988K Buy
+58,677
New +$999K ﹤0.01% 1286
2020
Q2 		– Sell
-15,844
Closed -$241K – 1471
2020
Q1 		$241K Buy
+15,844
New +$287K ﹤0.01% 1029
2019
Q2 		– Sell
-344,714
Closed -$7.02M – 1720
2019
Q1 		$7.02M Buy
+344,714
New +$6.94M 0.05% 481

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Dmitry Balyasny's TAK Position: Q2 2026 in Review

Dmitry Balyasny increased its Takeda Pharmaceutical (TAK) stake by 264% in Q2 2026, buying an estimated $6.14M and bringing the position to 511,336 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #1142.

Dmitry Balyasny first reported a position in TAK in Q1 2019 and has held it in 14 quarters since. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Dmitry Balyasny held 511,336 shares of Takeda Pharmaceutical worth $8.2M as of Q2 2026.
  • Dmitry Balyasny bought 370,758 Takeda Pharmaceutical shares in Q2 2026, an estimated $6.14M.
  • Takeda Pharmaceutical made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1142 holding.
  • Dmitry Balyasny first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 14 quarters since.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.